2026 Q1 Portfolio Activity
In 2026 Q1, Nan Fung Group Holdings Ltd maintained a portfolio of 29 distinct positions. The most significant new addition was CELCUITY INC, now representing 2.66% of the total fund value. They heavily accumulated shares in LB PHARMACEUTICALS INC, increasing the position by 110.2%. The fund also reduced its exposure to MADRIGAL PHARMACEUTICALS INC by 52.2%.
Position History
hover any row below to update
Loading…
Total Positions
29
Quarter
2026 Q1
Top Holding
EVMN (27.3%)
Top 10 Concentration
83.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-29 of 29
Nan Fung Group Holdings Ltd Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EVMN
EVOMMUNE INC
|
Healthcare | 27.32% | 22.08% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
1,441,032 | $33,129,326 |
$17.12
-33.4%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 16.28% | 15.27% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
971,253 | $19,745,573 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 12.82% | 5.98% |
#3
2
Prev: #5
|
8.0 |
—
|
330,657 | 110.2% |
P
S
|
630,657 | $15,552,002 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 7.69% | 9.20% |
#4
1
Prev: #3
|
3.6 |
—
|
-163,957 | -31.9% |
P
S
|
350,745 | $9,326,310 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
INCY
INCYTE CORP
|
Healthcare | 4.17% | 5.22% |
#5
1
Prev: #6
|
2.7 |
—
|
-5,280 | -8.9% |
P
S
|
53,742 | $5,058,197 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 3.85% | 4.28% |
#6
2
Prev: #8
|
2.5 |
—
|
no change | no change |
P
S
|
15,722 | $4,668,962 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 3.52% | 4.71% |
#7
Prev: #7
|
2.4 |
—
|
no change | no change |
P
S
|
49,120 | $4,271,966 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 2.66% | — |
#8
Prev: #—
|
4.6 |
—
|
28,300 | — |
NEW
|
28,300 | $3,230,162 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 2.57% | 2.60% |
#9
2
Prev: #11
|
2.0 |
—
|
no change | no change |
P
S
|
13,600 | $3,110,728 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PCOR
PROCORE TECHNOL...
|
Technology | 2.51% | 3.47% |
#10
1
Prev: #9
|
2.0 |
—
|
no change | no change |
P
S
|
53,299 | $3,038,043 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 2.45% | 6.19% |
#11
7
Prev: #4
|
1.0 |
—
|
-6,200 | -52.2% |
P
S
|
5,672 | $2,969,122 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 2.12% | 2.15% |
#12
3
Prev: #15
|
1.8 |
—
|
no change | no change |
P
S
|
30,875 | $2,571,579 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 1.89% | 2.46% |
#13
1
Prev: #12
|
1.8 |
—
|
no change | no change |
P
S
|
102,984 | $2,292,424 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CYBN
CYBIN INC
|
Unknown | 1.82% | 3.37% |
#14
4
Prev: #10
|
1.7 |
—
|
no change | no change |
P
S
|
460,000 | $2,208,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ARGX
ARGENX SE
|
Healthcare | 1.69% | 2.11% |
#15
1
Prev: #16
|
1.7 |
—
|
no change | no change |
P
S
|
2,800 | $2,044,700 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 1.54% | 1.37% |
#16
1
Prev: #17
|
1.6 |
—
|
no change | no change |
P
S
|
19,253 | $1,872,354 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RXRX
RECURSION PHARM...
|
Healthcare | 1.51% | 2.18% |
#17
4
Prev: #13
|
1.6 |
—
|
no change | no change |
P
S
|
595,287 | $1,827,531 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
INSM
INSMED INC
|
Healthcare | 0.89% | — |
#18
Prev: #—
|
3.9 |
—
|
6,580 | — |
NEW
|
6,580 | $1,075,962 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ETHA
ISHARES ETHEREU...
|
ETF | 0.66% | 1.01% |
#19
1
Prev: #18
|
1.3 |
—
|
no change | no change |
P
S
|
50,549 | $800,191 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.62% | 0.91% |
#20
1
Prev: #19
|
1.2 |
—
|
no change | no change |
P
S
|
27,049 | $757,642 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TRDA
ENTRADA THERAPE...
|
Healthcare | 0.51% | 0.45% |
#21
2
Prev: #23
|
1.2 |
—
|
no change | no change |
P
S
|
49,082 | $619,415 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IBIT
ISHARES BITCOIN...
|
Bond/Debt | 0.51% | 0.71% |
#22
2
Prev: #20
|
1.2 |
—
|
no change | no change |
P
S
|
15,968 | $613,491 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RANI
RANI THERAPEUTI...
|
Healthcare | 0.30% | 0.60% |
#23
2
Prev: #21
|
1.1 |
—
|
no change | no change |
P
S
|
493,584 | $362,686 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BOLT
BOLT BIOTHERAPE...
|
Healthcare | 0.10% | 0.29% |
#24
1
Prev: #25
|
0.0 |
—
|
-29,097 | -49.9% |
P
S
|
29,250 | $118,170 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BSLK
BOLT PROJS HLDG...
|
Basic Materials | 0.00% | 0.03% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-40,597 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RKLB
ROCKET LAB CORP
|
Industrials | 0.00% | 0.24% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-3,824 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BCYC
BICYCLE THERAPE...
|
Healthcare | 0.00% | 0.44% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-68,943 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-63,719 | -100.0% |
CLOSED
|
— | $— | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
LAB
STANDARD BIOTOO...
|
Healthcare | 0.00% | 2.16% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-1,883,179 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 |
Showing 1-29 of 29 holdings